Inhibition of Oral Pathogens and Collagenase Activity by Seaweed Extracts
Inhibition of Oral Pathogens and Collagenase Activity by Seaweed Extracts
Inhibition of Oral Pathogens and Collagenase Activity by Seaweed Extracts
net/publication/232006119
CITATIONS READS
33 470
6 authors, including:
Jae-Suk Choi
Gyeongsang National University
228 PUBLICATIONS 2,512 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Development and commercialization of traditional seafood products based on the Korean coastal marine resources View project
All content following this page was uploaded by Jae-Suk Choi on 01 September 2015.
Abstract
Fifty-seven species of common seaweed from the Coast of Korea were screened for antimicrobial (i.e.
inhibition of Prevotella intermedia and Porphyromonas gingivalis growth) activity. As a source of bioactive
compounds, seaweeds can produce many secondary metabolites with a variety of activities. Using the agar
Publication Data diffusion method, only 17 species (29.8% ) showed inhibitory activity. Of these, methanol extracts of
Enteromorpha linza, Sargassum sagamianum, and Ulva pertusa showed strong inhibitory effects against both
Paper received: P. intermedia and P. gingivalis. The MIC values of E. linza, S. sagamianum, and U. pertusa extracts against
12 June 2010 P. intermedia were 625, 78 and 625 µg ml-1 and those against P. gingivalis were 312, 156 and 625 µg ml-1,
respectively. When these three species’ extracts were separated into five fractions according to their polarity,
Revised received: the main active agents were determined to be phenolic compounds. We then compared the antimicrobial
03 March 2011 activities of these phenolic compounds against various periodontal pathogens using a MIC test. Phenolic
compound containing extracts at concentrations of 10 to 100 µg ml-1 showed a moderate to significant
Accepted: inhibitory effect on collagenase 1, 2 and 3 activity.
21 April 2011
Key words
Antimicrobial activity, Seaweed extracts, Periodonititis, Prevotella intermedia, Porphyromonas gingivalis,
Collagenase
Table - 2: Antimicrobial activity against P. intermedia and P. gingivalis in seaweed methanol extracts, as determined by the disk diffusion method.
P. intermedia P. gingivalis
Seaweeds
-1 -1 -1 -1
1 mg disk 3 mg disk 5 mg disk 1 mg disk 3 mg disk-1 5 mg disk-1
Ahnfeltiopsis flabelliformis - - - - - +
Costaria costata - - - + ++ ++
Desmarestia viridis - - - + ++ ++
Enteromorpha linza - ++ +++ + ++ +++
Ishige okamurae - - - + ++ ++
Ishige sinicola - - - - + ++
Laminaria japonica - + ++ + + ++
Lomentaria catenata - - - - - +
Myagropsis myagroides - - - - ++ ++
Myelophycus simplex - - - - - +
Pachydictyon coriaceum - - - ++ +++ ++++
Petalonia fascia - - - - +
Sargassum horneri - - - + ++ ++
Sargassum sagamianum - ++ +++ ++ ++ +++
Scytsiphon lomentaria - + + + + ++
Ulva pertusa - ++ +++ ++ +++ ++++
Undaria pinnatifida - + ++ + + ++
Inhibition zone diameter was measured (+ = < 4 mm, ++ = 4 - 8 mm; +++ = 8 - 12 mm; ++++ = > 12 mm). Data are mean of triplicate determinations.
857440) was included in the assays as a positive control. All disk solution were distributed into wells of a 96 well plate. Diluted MMP
diffusion tests were performed independently in triplicate. enzymes and phenolic compounds (20 µl of each) were added,
reaction mixtures were incubated for 30 min at 37oC and diluted
Determination of MIC values: Seaweed extracts and fractions substrate (thiopeptide; 10 µl) was added. The final volume was
that showed strong activity were investigated further by a broth brought up to 100 µl immediately. Inhibition was measured by
microdilution assay, following the guidelines of the National Committee continuously reading plates at A412 for 20 min in a microplate reader
for Clinical and Laboratory Standards (NCCLS) for anaerobic (Spectra MAX 190, Molecular Devices, CA, USA). Inhibition percent
bacteria M11-A6 (NCCLS, 2004), aerobic bacteria M7-A6 (NCCLS, activity remaining were analyzed by dividing reaction velocity of
2003) and yeasts M27-A2 (NCCLS, 2002) in a 96-well U-shaped inhibitor with control and quotient multiplied with 100. All assays
microplate. Inocula were prepared from 24 hr broth cultures and were performed independently in triplicate.
suspensions were adjusted to 0.5 McFarland standard solution
turbidity. Seaweed extracts or fractions were first diluted to the highest Acute toxicity test: Acute toxicity of the moderately polar
concentration (10 µg ml-1) to be tested and then serial two-fold fractions was assessed in BALB/c mice (8-10 weeks old; 20-25
dilutions were made, resulting in concentrations ranging from 19.5 µg g body weight) (Cho et al., 2007). Animals were kept at room
to 10 µg ml-1. Microtitre plates were prepared by dispensing the temperature (24±1oC) on a 12/12 hr light/dark cycle with free
access to food and water. For the acute toxicity test, mice were
inoculum and sample (100 µl of each) into each well. The first well
fasted for 6 hr with water provided ad libitum. Phenolic fractions
of each strip contained 100 µl broth with no compound and 100 µl
were evaporated under vacuum at 35 oC using a rotary
inoculum, and represented the negative control. The second well
evaporator and then administered orally (5 g 10 ml -1 corn oil of
on each strip contained 90 µl broth, 10 µl methanol and 100 µl
5% DMSO kg b.wt. -1) to mice (n = 5). Animals were observed
inoculum, and represented the positive control. The final volume in
for any abnormal behavior for 3 hr and any mortality was
each well was 200 µl. Plates were incubated appropriately for recorded for up to 2 weeks. A group of animals treated with
each microorganism (Table 1). The MIC value was defined as the DMSO only served as a control. Animal experiments were
lowest concentration that yielded no bacterial cell growth. All MIC performed in accordance with the U.S. NIH Guidelines for the
tests were performed independently in triplicate. The antimicrobial Care and Use of Laboratory Animals.
agent chloramphenicol (Sigma 857440) was included in the assays
as a positive control. Statistics: Each independent assay was repeated at least three
times with separate cultures. Treatment means were compared to
Measurement of collagenase activity: To investigate controls using student’s t-test.
collagenase inhibition, 10 and 100 µg ml-1 concentrations of the
phenolic fraction of extracts were used. Collagenase 1 (MMP-1), 2 Results and Discussion
(MMP-8) and 3 (MMP-13) activity was measured using a MMP Screening of antimicrobial activity: Of the 57 seaweed species
Colorimetric Drug Discovery Kit: AK-404, AK-414 and AK-412 (Enzo screened, only six (10.5%) showed antimicrobial activity against P.
Life Science, Plymouth, PA, USA). Briefly, aliquots (50 µl) of buffer intermedia and 17 (29.8%) against P. gingivalis (Table 2). Among
the 10 species of Chlorophyta (green algae) screened, only two Fractionation of crude extracts: Each seaweed powder (20 g)
(Enteromorpha linza and Ulva pertusa; 20.0%) inhibited both was extracted in 1 l of a methanol-water (4:1) mixed three times,
microbial pathogens. Phaeophyta (brown algae) showed the highest and the crude extract was evaporated, yielding a dark greenish-
activity (37.9%) among the three classes of seaweeds screened. brown gummy residue. The fraction that was acidified to pH 2 and
Two species showed anti P. intermedia and 11 showed anti-P. extracted with chloroform yielded a moderately polar mixture of
gingivalis activity. Of the Rhodophyta (red algae), antimicrobial activity phenolic compounds (0.68, 1.30 and 0.42 g), which contained the
was present only at low levels in two species. The strongest activities majority of the antimicrobial activity. The MIC values of the phenolic
against both microbial pathogens among chlorophyta seaweed fractions of E. linza, S. sagamianum, and U. pertusa extracts against
species were exhibited by E. linza and U. pertusa; while among P. intermedia were 156, 78 and 78 µg ml-1, respectively. The MIC
Phaeophyta, the activity of S. sagamianum was highest. The values of the phenolic fractions of E. linza, S. sagamianum and U.
inhibition zones of chloramphenicol (positive control; 0.5 mg disk-1) pertusa extracts against P. gingivalis were 156, 78 and 312 µg ml-1,
were 14 and 15 mm, respectively. respectively (Table 4).
MIC values determination: The MIC values were determined MIC values of phenolics against several oral pathogens: To
using a two-fold serial dilution method. The MIC values of E. linza, determine the antimicrobial activities of phenolic fractions against
S. sagamianum and U. pertusa extracts against P. intermedia were recognized oral pathogens, MIC values were determined by the
625, 78 and 625 µg ml-1, respectively. The MIC values of E. linza, broth microdilution assay (Table 5). The MIC values of phenolic
S. sagamianum and U. pertusa extracts against P. gingivalis were fractions of E. linza, S. sagamianum, and U. pertusa extracts against
312, 156 and 625 µg ml-1, respectively. The MICs of chloramphenicol Candida albicans were 625, 78 and 312 µg ml-1, respectively. The
(positive control) against P. intermedia and P. gingivalis were 2 and MIC values against Fusobacterium nucleatum subsp. vincenti were
1 µg ml-1, respectively (Table 3). 625, 78 and 156 µg ml -1 and against Haemophilus
actinomycetemcomitans were 625, 312 and 625 µg ml-1, respectively.
Table - 3: MIC values (µg ml-1) against P. intermedia and P. gingivalis of The MIC values of S. sagamianum and U. pertusa against
methanol extracts, as determined by broth microdilution assay. Streptococcus mutans were 625 and 1,250 µg ml-1, respectively.
Seaweeds P. intermedia P. gingivalis The phenolic fraction of E. linza extract showed no inhibitory effect
against Streptococcus mutans. The three phenolics exhibited
Enteromorpha linza 625 312
Sargassum sagamianum 78 156
moderate to significant inhibition of all oral pathogens tested, except
Ulva pertusa 625 625 the phenolics of E. linza against S. mutans. The MICs of
chloramphenicol (positive control) against P. intermedia and
The MIC values were measured for 48 hr after incubation
P. gingivalis were 2 and 1 µg ml-1, respectively.
Table - 4: Comparison of antimicrobial activity against P. intermedia and P. gingivalis of seaweed extract fractions by MIC test
MIC values against P. intermedia (µg ml-1)
Seaweeds
Saccharides Lipids Phenolics Alkaloids Nitrogen compounds
Table - 5: MIC values of seaweed extract phenolic fractions against several oral pathogens.
MIC values of phenolics (µg ml-1)
Oral pathogens
E. linza S. sagamianum U. pertusa
Lazarus, G.S., J.R. Daniels, R.S. Brown, H.A. Bladen and H.M. Fullmer: Standard, 6th Edn. NCCLS Document M11-A6. Villanova, Pa, NCCLS
Degradation of collagen by a human granulocyte collagenolytic (2004).
system. J. Clin. Invest., 47, 2622-2629 (1968). Niederau, W., U. Hoffer and G. Pulverer: Susceptibility of B. melaninogenicus
Lee, W., S. Aitken, J. Sodek and C.A. McCulloch: Evidence of a direct to 45 antibiotics. Chemotherapy, 26, 121-127 (1980).
relationship between neutrophil collagenase activity and periodontal Oh, Y.S., I.K. Lee and S.M. Boo: An annotated account of Korean economic
tissue destruct ion in viv o: Role of active enzy me in hum an seaweeds for food, medical and industrial uses. Korean J. Phycol.,
periodontitis. J. Periodontal. Res., 30, 23-33 (1995). 5, 57-71 (1990).
Mayer, A.M.S., V.J. Paul, W. Fenical, J.N. Norris, M.S. de Carvalho and Park, K.M., J.H. Choo, J.H. Sohn, S.H. Lee and J.K. Hwang: Antibacterial
R.S. Jac obs: Phospholipase A 2 inhibitors from marine algae. activity of panduratin A isolated from Kaempferia pandurata against
Hydrobiologia, 260/261, 521-529 (1993). Porphyromonas gingivalis. Food Sci. Biotechnol., 14, 286-289 (2005).
Mayer, A.M.S. and M.T. Hamann: Marine pharmacology in 2000: Marine Robertson, P.B. and J. Simpson: Collagenase: Current concepts and
compounds with antibact erial, anticoagulant, antifungal, anti- relevance to periodontal disease. J. Periodontol., 47, 29-33 (1976).
inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral Slots, J. and M. Ting: Systemic antibiotics in the treatment of periodontal
activities; affecting the cardiovascular, immune and nervous systems disease. Periodontol. 2000, 28, 106-176 (2002).
and other miscellaneous mechanisms of action. Mar. Biotechnol., 6, Socransky, S.S., A.D. Haffajee, L.A. Ximénez-Fyvie, M. Feres and D.
37-52 (2004). Mager: Ecological considerations in the treatment of Actinobacillus
Newman, D.J., G.M. Cragg and K.M. Snader: Natural products as sources actinomycetemcomitans and Porphyromonas gingivalis periodontal
of new drugs over the period 1981-2002. J. Nat. Prod., 66, 1022-1037 infections. Periodontol. 2000, 20, 341-362 (1999).
(2003). Uitto, V.J., K. Airola, M. Vaalamo, N. Johansson, E.E. Putnis, J.D. Firth, J.
National Committee for Clinical Laboratory Standards: Reference methods Salonen, U. Saarialhokere and V.M. Kahari: Collagenase-3 (matrix
for broth dilution antifungal susceptibility testing of yeasts; Approved met alloprot einase-13) expression is induced in oral mucosal
Standard, 2nd Edn. NCCLS Document M27-A2. Villanova, Pa, NCCLS epit helium during c hronic inflamm ation. Am . J . Pathol., 152,
(2002). 1489-1499 (1998).
National Committee for Clinical Laboratory Standards: Methods for dilution Wahl, L.M., S.M. Wahl, S.E. Mergenhagen and G.R. Martin: Collagenase
antimicrobial susceptibility tests for bacteria that grow aerobically; product ion by lymphokine-act ivated macrophages. Sc i. , 187,
Approved Standard, 6 th Edn. NCCLS Document M7-A6. Villanova, 261-263 (1975).
Pa, NCCLS (2003). WHO: Research guidelines for evaluating the safety and efficacy of herbal
National Committee for Clinical Laboratory Standards: Methods for medicine. Regional office for Western Pacific, Manila, Philippines.
antimicrobial susceptibility testing of anaerobic bacteria; Approved pp. 1-38 (1992).